These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 852233
1. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation]. Forconi S, Guerrini M. Clin Ter; 1977 Feb 15; 80(3):229-55. PubMed ID: 852233 [No Abstract] [Full Text] [Related]
2. Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography. Forconi S, Guerrini M, Di Perri T. Vasa; 1977 Feb 15; 6(3):279-84. PubMed ID: 335696 [No Abstract] [Full Text] [Related]
3. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency]. Barbarino C, Pezzangora V. Vasa Suppl; 1989 Feb 15; 27():120. PubMed ID: 2623482 [No Abstract] [Full Text] [Related]
4. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease. Bielawiec M, Lukjan H, Kiersnowska-Rogowska B, Dabrowski S. Bibl Anat; 1979 Feb 15; (18):378-81. PubMed ID: 496871 [No Abstract] [Full Text] [Related]
5. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders]. Bopp J. Med Welt; 1977 Oct 14; 28(41):1660-4. PubMed ID: 927128 [No Abstract] [Full Text] [Related]
6. [Supportive drug therapy of varicose veins with venelbin]. Ohler R. Fortschr Med; 1978 Nov 09; 96(42):2173-7. PubMed ID: 711110 [No Abstract] [Full Text] [Related]
7. Effect of O-(beta-hydroxyethyl)-rutoside on the glucose metabolism of cultured human varicose saphenous veins. Matagne D, Gilles R. Arch Int Physiol Biochim; 1977 Feb 09; 85(1):133-8. PubMed ID: 68718 [Abstract] [Full Text] [Related]
8. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease. Bielawiec M, Lukjan H, Grabowski R, Myśliwiec M, Korfel B. Bibl Anat; 1977 Feb 09; (16 Pt 2):152-4. PubMed ID: 603503 [No Abstract] [Full Text] [Related]
9. [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency]. Stemmer R, Furderer CR. Phlebologie; 1986 Feb 09; 39(4):995-1003. PubMed ID: 3562569 [Abstract] [Full Text] [Related]
10. Comparative investigations on the treatment of the varicose syndrome with 4-methyl-6,7-(bis-beta-diethyl-aminoethoxy)-coumarine hydrochloride (oxamarine), with the disodium salt of disulphuric ester of 4-methyl-aesculetol and with tri-hydroxy-ethylrutoside (troxerutin). Frandoli G, Turazza G, Spreafico PL. Panminerva Med; 1972 Sep 09; 14(9):290-5. PubMed ID: 4618898 [No Abstract] [Full Text] [Related]
11. [Drug therapy of venopathies]. Esser W. Fortschr Med; 1975 Oct 23; 93(30):1506-7. PubMed ID: 1225812 [No Abstract] [Full Text] [Related]
12. [Sclerosing of varicose veins and additional medication. Are disease course and results affected by combined therapy? An experience report]. Böhme D. ZFA (Stuttgart); 1980 May 10; 56(13):953-9. PubMed ID: 7415464 [No Abstract] [Full Text] [Related]
13. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins. Matagne D, Hamoir G. Biochem Pharmacol; 1975 Aug 15; 24(16):1491-4. PubMed ID: 1191306 [No Abstract] [Full Text] [Related]
18. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood. van Haeringen NJ. Bibl Anat; 1975 Jun 15; 13():197-9. PubMed ID: 1231726 [No Abstract] [Full Text] [Related]
20. The effect of O-betahydroxyethyl-rutosides (HR) on the number of platelet-leukocyte aggregates in patients with occlusive arterial disease. Bielawiec M, Kiersnowska-Rogowska B, Dabrowski S, Lukjan H. Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Jun 15; 106(1):103-8. PubMed ID: 88383 [Abstract] [Full Text] [Related] Page: [Next] [New Search]